Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Food drugs as drivers of therapeutic knowledge and the role of chemosensory qualities

  • Leonti, Marco
  • Cabras, Stefano
  • Castellanos Nueda, María Eugenia
  • Casu, Laura
Ethnopharmacological relevance: Chemosensory qualities of botanical drugs are important cues for anticipating physiologic consequences. Whether a botanical drug is used for both, food and medicine, or only as medicine depends on taste preferences, nutritional content, cultural background, and the individual and overall epidemiological context., Material and methods: We subjected 540 botanical drugs described in De Materia Medica having at least one oral medical application to a tasting panel. The 540 drugs were grouped into those only used for medicine (388) and those also used for food (152). The associations with chemosensory qualities and therapeutic indications were compared across the two groups. We considered 22 experimentally assessed chemosensory qualities and 39 categories of therapeutic use groups. We wanted to know, 1): which chemosensory qualities increase the probability of an orally applied botanical drug to be also used for food ? 2): which chemosensory qualities augment the probability of an orally applied botanical drug to be only used for medicine? and 3): whether there are differences in therapeutic indications between orally applied botanical drugs also used for food (food drugs) and botanical drugs applied exclusively for medicinal purposes (non-food drugs) and, if yes, how the differences can be explained., Results: Chemosensory qualities augmenting the probability of an orally applied botanical drug to be also used for food were sweet, starchy, salty, burning/hot, fruity, nutty, and cooling. Therapeutics used for diarrhoea, as libido modulators, purgatives, laxatives, for expelling parasites, breast and lactation and increasing diuresis, were preferentially sourced from food drugs while drugs used for liver and jaundice, vaginal discharge and humoral management showed significant negative associations with food dugs in ancient Greek-Roman materia medica., Conclusion: Therapeutics used for ailments of body organs involved in the digestion of food and the excretion of waste products showed a tendency to be sourced from food drugs. Arguably, the daily consumption of food offered the possibility for observing post-prandial physiologic and pharmacologic effects which led to a high therapeutic versatility of food drugs and the possibility to understand benefits of taste and flavour qualities. The difference in chemosensory qualities between food drugs and non-food drugs is demarcating the organoleptic requirements of food rather than that of medicine., This project has received funding from the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 606895.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publicación Artículo científico (JournalArticle)

Reverse ethnopharmacology and drug discovery

  • Leonti, Marco
  • Stafford, Gary I.
  • Dal Cero, Maja
  • Cabras, Stefano
  • Castellanos, María Eugenia
  • Casu, Laura
  • Weckerle, Caroline S.
ETHNOPHARMACOLOGICAL RELEVANCE: Ethnopharmacological investigations of traditional medicines have made significant contributions to plant-derived drugs, as well as the advancement of pharmacology. Drug discovery from medicinal flora is more complex than generally acknowledged because plants are applied for different therapeutic indications within and across cultures. Therefore we propose the concept of “reverse ethnopharmacology” and compare biomedical uses of plant taxa with their ethnomedicinal and popular uses and test the effect of these on the probability of finding biomedical and specifically anticancer drugs. MATERIALS AND METHODS: For this analysis we use data on taxonomy and medical indications of plant derived biomedical drugs, clinical trial, and preclinical trial drug candidates published by Zhu et al. (2011) and compare their therapeutic indications with their ethnomedicinal and popular uses as reported in the NAPRALERT® database. Specifically, we test for increase or decrease of the probability of finding anticancer drugs based on ethnomedicinal and popular reports with Bayesian logistic regression analyses. RESULTS: Anticancer therapy resulted as the most frequent biomedicinal indication of the therapeutics derived from the 225 drug producing higher plant taxa and showed an association with ethnomedicinal and popular uses in women's medicine, which was also the most important popular use-category. Popular remedies for dysmenorrhoea, and uses as emmenagogues, abortifacients and contraceptives showed a positive effect on the probability of finding anticancer drugs. Another positive effect on the probability of discovering anticancer therapeutics was estimated for popular herbal drugs associated with the therapy of viral and bacterial infections, while the highest effect was found for popular remedies used to treat cancer symptoms. However, this latter effect seems to be influenced by the feedback loop and divulgence of biomedical knowledge on the popular level. CONCLUSION: We introduce the concept of reverse ethnopharmacology and show that it is possible to estimate the probability of finding biomedical drugs based on ethnomedicinal uses. The detected associations confirm the classical ethnopharmacological approach where a popular remedy for disease category X results in a biomedical drug for disease category X but does also point out the existence of cross-over relationships where popular remedies for disease category X result in biomedical therapeutics for disease category Y (Zhu et al., 2011)., This paper is based on an oral presentation held at the 16th ISE Congress in Yulin, China (May 16-18th, 2016) and we would like to thank the organizers for the excellent congress and their hospitality. We are thankful also to Rich Spjut for the valuable comments on a draft version of this paper. GIS was a recipient of The Swiss Government Excellence Postdoctoral Scholarship awarded by the Federal Commission for Scholarships for Foreign Students (FCS). ML and CW acknowledge funding from the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no. 606895. SC gratefully acknowledges funding from the RYC-2012-11455 and ECO2015-66593-P. MEC and SC acknowledge funding of the MINECO-Spain project (MTM2013-42323-P and MTM2016-77501-P).
Dipòsit Digital de la UB
Publicación Artículo científico (JournalArticle)

A phylogenetic road map to antimalarial Artemisia species

  • Pellicer Moscardó, Jaume
  • Saslis-Lagoudakis, C. Haris
  • Carrió, Esperança
  • Ernst, Madeleine
  • Garnatje i Roca, Teresa
  • Grace, Olwen M.
  • Gras Mas, Airy
  • Mumbru Masip, Marius
  • Vallès Xirau, Joan, 1959-
  • Vitales Serrano, Daniel
  • Rønsted, Nina
Ethnopharmacological relevance The discovery of the antimalarial agent artemisinin is considered one of the most significant success stories of ethnopharmacological research in recent times. The isolation of artemisinin was inspired by the use of Artemisia annua in traditional Chinese medicine (TCM) and was awarded a Nobel Prize in 2015. Antimalarial activity has since been demonstrated for a range of other Artemisia species, suggesting that the genus could provide alternative sources of antimalarial treatments. Given the stunning diversity of the genus (c. 500 species), a prioritisation of taxa to be investigated for their likely antimalarial properties is required. Materials and methods Here we use a phylogenetic approach to explore the potential for identifying species more likely to possess antimalarial properties. Ethnobotanical data from literature reports is recorded for 117 species. Subsequent phylogenetically informed analysis was used to identify lineages in which there is an overrepresentation of species used to treat malarial symptoms, and which could therefore be high priority for further investigation of antimalarial activity. Results We show that these lineages indeed include several species with documented antimalarial activity. To further inform our approach, we use LC-MS/MS analysis to explore artemisinin content in fifteen species from both highlighted and not highlighted lineages. We detected artemisinin in nine species, in eight of them for the first time, doubling the number of Artemisia taxa known to content this molecule. Conclusions Our findings indicate that artemisinin may be widespread across the genus, providing an accessible local resource outside the distribution area of Artemisia annua.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A phylogenetic road map to antimalarial Artemisia species

  • Pellicer, Jaume
  • Saslis-Lagoudakis, C. Haris
  • Carrió, Esperança
  • Ernst, Madeleine
  • Garnatje, Teresa
  • Grace, Olwen M.
  • Gras, Airy
  • Mumbru, Màrius
  • Vallès, Joan
  • Vitales, Daniel
  • Rønsted, Nina
[Ethnopharmacological relevance] The discovery of the antimalarial agent artemisinin is considered one of the most significant success stories of ethnopharmacological research in recent times. The isolation of artemisinin was inspired by the use of Artemisia annua in traditional Chinese medicine (TCM) and was awarded a Nobel Prize in 2015. Antimalarial activity has since been demonstrated for a range of other Artemisia species, suggesting that the genus could provide alternative sources of antimalarial treatments. Given the stunning diversity of the genus (c. 500 species), a prioritisation of taxa to be investigated for their likely antimalarial properties is required., [Materials and methods] Here we use a phylogenetic approach to explore the potential for identifying species more likely to possess antimalarial properties. Ethnobotanical data from literature reports is recorded for 117 species. Subsequent phylogenetically informed analysis was used to identify lineages in which there is an overrepresentation of species used to treat malarial symptoms, and which could therefore be high priority for further investigation of antimalarial activity., [Results] We show that these lineages indeed include several species with documented antimalarial activity. To further inform our approach, we use LC-MS/MS analysis to explore artemisinin content in fifteen species from both highlighted and not highlighted lineages. We detected artemisinin in nine species, in eight of them for the first time, doubling the number of Artemisia taxa known to content this molecule., [Conclusions] Our findings indicate that artemisinin may be widespread across the genus, providing an accessible local resource outside the distribution area of Artemisia annua., This study was supported by the Marie Curie Actions of the 7th European Community Framework Programme: FP7/2007–2013, REA grant agreement no PIEF-GA-2012-328637-BiodiversityAltitude to C.H.S.L. and N.R. and 606895-MedPlant to N.R., as well as by the Agustí Pedro i Pons award 2012, Universitat de Barcelona, to E.C., and project 2014SGR514 of the Catalan government, project CGL2013-49097-C2-2-P of the Spanish government, and project 1-8/HEC/HRD/2013/2794 of the Pakistan government., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A phylogenetic road map to antimalarial Artemisia species

  • Pellicer Moscardó, Jaume
  • Saslis-Lagoudakis, C. Haris
  • Carrió, Esperança
  • Ernst, Madeleine
  • Garnatje i Roca, Teresa
  • Grace, Olwen M.
  • Gras Mas, Airy
  • Mumbru Masip, Marius
  • Vallès Xirau, Joan, 1959-
  • Vitales Serrano, Daniel
  • Rønsted, Nina
Ethnopharmacological relevance The discovery of the antimalarial agent artemisinin is considered one of the most significant success stories of ethnopharmacological research in recent times. The isolation of artemisinin was inspired by the use of Artemisia annua in traditional Chinese medicine (TCM) and was awarded a Nobel Prize in 2015. Antimalarial activity has since been demonstrated for a range of other Artemisia species, suggesting that the genus could provide alternative sources of antimalarial treatments. Given the stunning diversity of the genus (c. 500 species), a prioritisation of taxa to be investigated for their likely antimalarial properties is required. Materials and methods Here we use a phylogenetic approach to explore the potential for identifying species more likely to possess antimalarial properties. Ethnobotanical data from literature reports is recorded for 117 species. Subsequent phylogenetically informed analysis was used to identify lineages in which there is an overrepresentation of species used to treat malarial symptoms, and which could therefore be high priority for further investigation of antimalarial activity. Results We show that these lineages indeed include several species with documented antimalarial activity. To further inform our approach, we use LC-MS/MS analysis to explore artemisinin content in fifteen species from both highlighted and not highlighted lineages. We detected artemisinin in nine species, in eight of them for the first time, doubling the number of Artemisia taxa known to content this molecule. Conclusions Our findings indicate that artemisinin may be widespread across the genus, providing an accessible local resource outside the distribution area of Artemisia annua.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-term warming-induced trophic downgrading in the soil microbial food web

  • Borg Dahl, Mathilde|||0000-0003-3180-2543
  • Söllinger, Andrea|||0000-0001-5585-5880
  • Sigurðsson, Páll
  • Janssens, Ivan|||0000-0002-5705-1787
  • Peñuelas, Josep|||0000-0002-7215-0150
  • Sigurdsson, Bjarni D.|||0000-0002-4784-5233
  • Richter, Andreas|||0000-0003-3282-4808
  • Tveit, Alexander Tøsdal|||0000-0002-4163-3416
  • Urich, Tim
Climatic warming has been hypothesized to accelerate organic matter decomposition by soil microorganisms and thereby enhance carbon (C) release to the atmosphere. However, the long-term consequences of soil warming on belowground biota interactions are poorly understood. Here we investigate how geothermal warming by 6 °C for more than 50 years affects soil microbiota. Using metatranscriptomics we obtained comprehensive profiles of the prokaryotic, eukaryotic and viral players of the soil microbial food web. When compared to ambient soil temperature conditions, we found pronounced differences in taxa abundances within and between trophic modules of the soil food web. Specifically, we observed a 'trophic downgrading' at elevated temperature, with soil fauna decreasing in abundance, while predatory bacteria and viruses became relatively more abundant. We propose that the drivers for this shift are previously observed decreases in microbial biomass and soil organic carbon, and the increase in soil bulk density (decrease in soil porosity) at elevated temperature. We conclude that a trophic downgrading may have important implications for soil carbon sequestration and nutrient dynamics in a warming world.